{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T19:17:49Z","timestamp":1649186269467},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[1988,12,1]],"date-time":"1988-12-01T00:00:00Z","timestamp":596937600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceutisch Weekblad Scientific Edition"],"published-print":{"date-parts":[[1988,12]]},"DOI":"10.1007\/bf02219667","type":"journal-article","created":{"date-parts":[[2005,10,6]],"date-time":"2005-10-06T05:41:15Z","timestamp":1128577275000},"page":"272-276","source":"Crossref","is-referenced-by-count":0,"title":["The influence of ofloxacin and enoxacin on the metabolic pathways of theophylline in healthy volunteers"],"prefix":"10.1007","volume":"10","author":[{"given":"W. J. A.","family":"Wijnands","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T. J.","family":"Janssen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. J. M.","family":"Guelen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T. B.","family":"Vree","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T. M. C.","family":"de Witte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02219667_CR1","doi-asserted-by":"crossref","first-page":"295","DOI":"10.3109\/03602538308991392","volume":"14","author":"TJ Haley","year":"1983","unstructured":"Haley TJ. Metabolism and pharmacokinetics of theophylline in human neonates, children and adults. Drug Metab Rev 1983;14:295\u2013335.","journal-title":"Drug Metab Rev"},{"key":"BF02219667_CR2","first-page":"1105","volume-title":"Applied pharmacokinetcs","author":"L Hendeles","year":"1986","unstructured":"Hendeles L, Massanari M, Weinberg M. Theophylline. In: Evans WE, Schentag JJ, Jusko WJ, eds. Applied pharmacokinetcs. Spokane: Applied Therapeutics Inc., 1986:1105\u201388."},{"key":"BF02219667_CR3","doi-asserted-by":"crossref","first-page":"309","DOI":"10.2165\/00003088-198409040-00002","volume":"9","author":"JHG Jonkman","year":"1984","unstructured":"Jonkman JHG, Upton RA. Pharmacokinetic drug interactions with theophylline. Clin Pharmacokinet 1984;9:309\u201344.","journal-title":"Clin Pharmacokinet"},{"key":"BF02219667_CR4","first-page":"584","volume":"85","author":"RD Thomson","year":"1974","unstructured":"Thomson RD, Nagasawa HT, Jenne JW. Determination of theophylline and its metabolites in human urine and serum by high-pressure liquid chromatography. J Lab Clin Med 1974;85:584\u201393.","journal-title":"J Lab Clin Med"},{"key":"BF02219667_CR5","first-page":"215","volume-title":"The methylxanthine beverages and foods: chemistry, consumption and health aspects","author":"DW Yesair","year":"1984","unstructured":"Yesair DW, Branfman AR, Callahan MM. Human disposition and some biochemical aspects of methylxanthines. In: Spiller GA, ed. The methylxanthine beverages and foods: chemistry, consumption and health aspects. New York: Alan R. Liss Inc., 1984:215\u201333."},{"key":"BF02219667_CR6","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/S0140-6736(84)90283-6","volume":"2","author":"WJA Wijnands","year":"1984","unstructured":"Wijnands WJA, Van Herwaarden CLA, Vree TB. Enoxacin raises plasma theophylline concentrations. Lancet 1984;2:108\u20139.","journal-title":"Lancet"},{"key":"BF02219667_CR7","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/j.1365-2125.1985.tb05115.x","volume":"20","author":"WJA Wijnands","year":"1985","unstructured":"Wijnands WJA, Vree TB, Van Herwaarden CLA: Enoxacin decreases the clearance of theophylline in man. Br J Clin Pharmacol 1985;20:583\u20138.","journal-title":"Br J Clin Pharmacol"},{"key":"BF02219667_CR8","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1111\/j.1365-2125.1986.tb02957.x","volume":"22","author":"WJA Wijnands","year":"1986","unstructured":"Wijnands WJA, Vree TB, Van Herwaarden CLA. The influence of quinolone derivates on theophylline clearance. Br J Clin Pharmacol 1986;22:677\u201383.","journal-title":"Br J Clin Pharmacol"},{"issue":"suppl C","key":"BF02219667_CR9","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1093\/jac\/14.suppl_C.83","volume":"14","author":"BI Davies","year":"1984","unstructured":"Davies BI, Maesen FPV, Teengs JP. Serum and sputum concentrations of enoxacin after single oral dosing in a clinical and bacteriological study. J Antimicrob Chemother 1984;14(suppl C):83\u20139.","journal-title":"J Antimicrob Chemother"},{"key":"BF02219667_CR10","first-page":"32","volume":"88","author":"S Raoof","year":"1985","unstructured":"Raoof S, Wollschlager C, Khan F. Serum theophylline levels are increased by ciprofloxacin (Bay 9867), a new quinolone antibiotic. Chest 1985;88:32.","journal-title":"Chest"},{"key":"BF02219667_CR11","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1093\/jac\/18.6.719","volume":"18","author":"WJA Wijnands","year":"1986","unstructured":"Wijnands WJA, Van Griethuysen AJA, Vree TB, Van Klingeren B, Van Herwaarden CLA. Enoxacin in lower respiratory tract infections. J Antimicrob Chemother 1986;18:719\u201327.","journal-title":"J Antimicrob Chemother"},{"key":"BF02219667_CR12","unstructured":"Logamann C, Ohnhaus EE. Enoxacin, a differential inhibitor of the microsomal liver enzyme system in man. Abstract 26th Interscience Conference on Antimicrobial Agents and Chemotherapy, New Orleans, USA, 1987."},{"key":"BF02219667_CR13","doi-asserted-by":"crossref","unstructured":"Okazaki O, Miyazaki K, Tachizawa H. Lack of effect of ofloxacin on theophylline pharmacokinetics in rats. Chemotherapy 1987;502.","DOI":"10.1159\/000238528"},{"key":"BF02219667_CR14","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/clpt.1982.46","volume":"31","author":"DDS Tang-Liu","year":"1982","unstructured":"Tang-Liu DDS, Williams RL, Riegelman S. Nonlinear theophylline elimination. Clin Pharmacol Ther 1982; 31:358\u201369.","journal-title":"Clin Pharmacol Ther"},{"key":"BF02219667_CR15","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1002\/cpt1979265660","volume":"26","author":"JJ Grygiel","year":"1979","unstructured":"Grygiel JJ, Wing LMH, Farkas J, Birkett DJ. Effects of allopurinol on the theophylline metabolism and clearance. Clin PHarmacol Ther 1979;26:660\u20137.","journal-title":"Clin PHarmacol Ther"},{"key":"BF02219667_CR16","first-page":"672","volume":"10","author":"JO Miners","year":"1982","unstructured":"Miners JO, Attwood J, Birkett DJ. Theobromine metabolism in man. Drug Metab Dispos 1982;10:672\u20135.","journal-title":"Drug Metab Dispos"},{"key":"BF02219667_CR17","first-page":"271","volume":"8","author":"CJ Betlach","year":"1980","unstructured":"Betlach CJ, Tozer TN. Biodisposition of theophylline. Effect of aromatic hydrocarbon treatment in mice. Drug Metab Dispos 1980;8:271\u20133.","journal-title":"Drug Metab Dispos"},{"key":"BF02219667_CR18","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/j.1552-4604.1976.tb01528.x","volume":"16","author":"G Levy","year":"1976","unstructured":"Levy G, Koysooko R. Renal clearance of theophylline in man. J Clin Pharmacol 1976;16:329\u201332.","journal-title":"J Clin Pharmacol"},{"key":"BF02219667_CR19","first-page":"180","volume":"24","author":"DDS Tang-Liu","year":"1983","unstructured":"Tang-Liu DDS, Williams RL, Riegelman S. Disposition of caffeine and its metabolites in man. J Pharmacol Exp Ther 1983;24:180\u20135.","journal-title":"J Pharmacol Exp Ther"},{"key":"BF02219667_CR20","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/clpt.1981.193","volume":"30","author":"JJ Grygiel","year":"1981","unstructured":"Grygiel JJ, Birkett DJ. Cigarette smoking and theophylline clearance and metabolism. Clin Pharmacol Ther 1981;30:491\u20136.","journal-title":"Clin Pharmacol Ther"},{"key":"BF02219667_CR21","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/S0022-3476(83)80681-7","volume":"702","author":"KR Rosenberry","year":"1983","unstructured":"Rosenberry KR, Defusco CJ, Mansmann HC, McGeady SJ. Reduced theophylline half-life induced by carbamazepine therapy. J Pediatr 1983;702:472\u20134.","journal-title":"J Pediatr"},{"key":"BF02219667_CR22","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/clpt.1981.36","volume":"29","author":"RL Manfredi","year":"1981","unstructured":"Manfredi RL, Vesell ES. Inhibition of theophylline metabolism by long term allopurinol administration. Clin Pharmacol Ther 1981;29:224\u20139.","journal-title":"Clin Pharmacol Ther"},{"key":"BF02219667_CR23","doi-asserted-by":"crossref","first-page":"68","DOI":"10.7326\/0003-4819-95-1-68","volume":"95","author":"MA Campbell","year":"1981","unstructured":"Campbell MA, Plachetka JR, Jackson JE, Moon JF, Finley PR. Cimetidine decreases theophylline clearance. Ann Intern Med 1981;95:68\u20139.","journal-title":"Ann Intern Med"},{"key":"BF02219667_CR24","first-page":"335","volume":"26","author":"JJ Grygiel","year":"1984","unstructured":"Grygiel JJ, Miners JO, Drew R, Brikett DJ. Differential effects of cimetidine on theophylline metabolic pathways. Eur J Pharmacol 1984;26:335\u201340.","journal-title":"Eur J Pharmacol"},{"key":"BF02219667_CR25","first-page":"615","volume":"123","author":"JE Jackson","year":"1981","unstructured":"Jackson JE, Powell JR, Wandell M. Cimetidine decreases theophylline clearance. Am Rev Respir Dis 1981;123:615\u20137.","journal-title":"Am Rev Respir Dis"},{"key":"BF02219667_CR26","doi-asserted-by":"crossref","first-page":"582","DOI":"10.7326\/0003-4819-95-5-582","volume":"95","author":"DP Reitberg","year":"1981","unstructured":"Reitberg DP, Berhard H, Schentag JJ. Alteration of theophylline clearance and half-life by cimetidine in normal volunteers. Ann Intern Med 1981;95:582\u20135.","journal-title":"Ann Intern Med"},{"key":"BF02219667_CR27","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1038\/clpt.1981.182","volume":"30","author":"KW Renton","year":"1981","unstructured":"Renton KW, Gray JD, Hung OR, Depression of theophylline elimation by erythromycin. Clin Pharmacol Ther 1981;30:422\u20136.","journal-title":"Clin Pharmacol Ther"},{"key":"BF02219667_CR28","first-page":"821","volume":"101","author":"RK Roberts","year":"1983","unstructured":"Roberts RK, Grice J, McGuffie C, Heilbronn L. Oral contraceptive steroids impair the elimination of theophylline. J Lab Clin Med 1983;101:821\u20135.","journal-title":"J Lab Clin Med"},{"key":"BF02219667_CR29","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/BF00545966","volume":"23","author":"KM Tornatore","year":"1982","unstructured":"Tornatore KM, Kanarkowski R, McCarthy TL, Gardner MJ, Jusko WJ. Effect of chronic oral contraceptive steroids on theophylline disposition. Eur J Clin Pharmacol 1982;23:129\u201334.","journal-title":"Eur J Clin Pharmacol"},{"issue":"suppl 1","key":"BF02219667_CR30","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2165\/00003495-198700341-00034","volume":"34","author":"WJA Wijnands","year":"1987","unstructured":"Wijnands WJA, Vree TB, Baars AM, Van Herwaarden CLA. Steady-state kinetics of the quinolone derivatives ofloxacin, enoxacin, ciprofloxacin, and pefloxacin during maintenance treatment with theophylline. Drugs 1987;34(suppl 1):159\u201369.","journal-title":"Drugs"},{"key":"BF02219667_CR31","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1177\/106002808602000502","volume":"20","author":"M Nazario","year":"1986","unstructured":"Nazario M. The hepatic and renal mechanisms of drug interactions with cimetidine. Drug Intell Clin Pharm 1986;20:342\u20138.","journal-title":"Drug Intell Clin Pharm"}],"container-title":["Pharmaceutisch Weekblad"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02219667.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02219667\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02219667","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,14]],"date-time":"2019-05-14T18:04:24Z","timestamp":1557857064000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02219667"}},"subtitle":["A pilot study"],"short-title":[],"issued":{"date-parts":[[1988,12]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1988,12]]}},"alternative-id":["BF02219667"],"URL":"https:\/\/doi.org\/10.1007\/bf02219667","relation":{},"ISSN":["0031-6911","1573-739X"],"issn-type":[{"value":"0031-6911","type":"print"},{"value":"1573-739X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1988,12]]}}}